CLINICAL PROFILE AND IMMEDIATE OUTCOME OF NEONATAL SEPSIS IN A TERTIARY CARE NEONATAL INTENSIVE CARE UNIT: A PROSPECTIVE OBSERVATIONAL STUDY
DOI:
https://doi.org/10.48047/t51mmt24Keywords:
neonatal sepsis; blood culture; early-onset sepsis; NICU; outcome; South IndiaAbstract
Background: Neonatal sepsis is a leading cause of neonatal mortality in developing countries. Characterising its clinical profile, bacteriology and immediate outcome guides empirical therapy and care. Objectives: To describe the clinical profile, risk factors, bacteriological spectrum and immediate outcome of neonates with sepsis admitted to a tertiary neonatal intensive care unit (NICU). Methods: A prospective observational study of 100 neonates with clinically suspected or culture-confirmed sepsis recorded perinatal risk factors, clinical features, sepsis screen, blood culture, complications and outcome. Groups (early- vs late-onset) were compared descriptively. Results: Of 100 neonates (55% male; mean gestation 36.6 ± 3.0 weeks; mean birth weight 2663 ± 633 g), 54% had early-onset and 46% late-onset sepsis. Poor feeding (100%), lethargy (76%) and respiratory distress (57%) were the commonest features. Blood culture was positive in 33%; the leading isolates were Staphylococcus aureus (11), Group B Streptococcus (10), Escherichia coli (5), Acinetobacter species (4) and Klebsiella pneumoniae (3). Shock occurred in 14% and mechanical ventilation was required in 20%; mean stay was 14.5 ± 6.1 days. Overall, 74% were discharged alive, 23% transferred and 3% died. Conclusion: Neonatal sepsis presented with non-specific features, a culture-positivity rate of one-third dominated by S. aureus and Gram-negative organisms, and low immediate mortality with intensive care. The findings support a high index of suspicion, prompt sepsis screening and locally informed empirical antibiotic choice.
Downloads
References
Zea-Vera A, Ochoa TJ. Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr. 2015;61(1):1–13. doi:10.1093/tropej/fmu079
Hoffman JA, Mason EO, Schutze GE, Tan TQ, Barson WJ, Givner LB, et al. Streptococcus pneumoniae infections in the neonate. Pediatrics. 2003;112(5):1095–1102. doi:10.1542/peds.112.5.1095
Downie L, Armiento R, Subhi R, Kelly J, Clifford V, Duke T. Community-acquired neonatal and infant sepsis in developing countries: efficacy of WHO’s currently recommended antibiotics — systematic review and meta-analysis. Arch Dis Child. 2013;98(2):146–154. doi:10.1136/archdischild-2012-302033
Chacko B, Sohi I. Early onset neonatal sepsis. Indian J Pediatr. 2005;72(1):23–26. doi:10.1007/BF02760574
Weisman LE. Coagulase-negative staphylococcal disease: emerging therapies for the neonatal and pediatric patient. Curr Opin Infect Dis. 2004;17(3):237–241. doi:10.1097/00001432-200406000-00011
Sankar MJ, Agarwal R, Deorari AK, Paul VK. Sepsis in the newborn. Indian J Pediatr. 2008;75(3):261–266. doi:10.1007/s12098-008-0056-z
Bhat Y R, Lewis LES, K E V. Bacterial isolates of early-onset neonatal sepsis and their antibiotic susceptibility pattern between 1998 and 2004: an audit from a center in India. Ital J Pediatr. 2011;37:32. doi:10.1186/1824-7288-37-32
Shah AJ, Mulla SA, Revdiwala SB. Neonatal sepsis: high antibiotic resistance of the bacterial pathogens in a neonatal intensive care unit of a tertiary care hospital. J Clin Neonatol. 2012;1(2):72–75. doi:10.4103/2249-4847.96753
Charoo BA, Iqbal JI, Iqbal Q, Mushtaq S, Bhat AW, Nawaz I. Nosocomial sepsis-induced late onset thrombocytopenia in a neonatal tertiary care unit: a prospective study. Hematol Oncol Stem Cell Ther. 2009;2(2):349–353. doi:10.1016/s1658-3876(09)50024-6
Sawardekar KP. Changing spectrum of neonatal omphalitis. Pediatr Infect Dis J. 2004;23(1):22–26. doi:10.1097/01.inf.0000105200.18110.1e.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
